Zusammenfassung: Rhythmusst\u00f6rungen vom Typ Torsade de Pointes (TdP) sind eine potentiell lebensbedrohliche unerw\u00fcnschte Wirkung (UAW) von solchen Arzneimitteln, die das QT-Intervall im Oberfl\u00e4chen-EKG verl\u00e4ngern. Nicht nur Kardiaka, sondern auch zahlreiche Substanzen mit nicht-kardialer Indikation k\u00f6nnen dies bewirken. Die Besonderheiten dieser speziellen UAW m\u00fcssen jedem bekannt sein, der diese Arzneimittel einsetzt bzw. verschreibt. Die Zulassungsbeh\u00f6rden sind […]<\/p>\n","protected":false},"excerpt":{"rendered":"
Zusammenfassung: Rhythmusst\u00f6rungen vom Typ Torsade de Pointes (TdP) sind eine potentiell lebensbedrohliche unerw\u00fcnschte Wirkung (UAW) von solchen Arzneimitteln, die das QT-Intervall im Oberfl\u00e4chen-EKG verl\u00e4ngern. Nicht nur Kardiaka, sondern auch zahlreiche Substanzen mit nicht-kardialer Indikation k\u00f6nnen dies bewirken. Die Besonderheiten dieser speziellen UAW m\u00fcssen jedem bekannt sein, der diese Arzneimittel einsetzt bzw. verschreibt. Die Zulassungsbeh\u00f6rden sind […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[4002,980,127,3830,618,1436,126,916,918,757,331,1745,4003,271,586,817,2409,613,915,110,585,345,2055,913,1692,1693,760,914,335,492,994,289,1685,1684,920,2410,1689,1892,654,2253,187,1252,761,2473,2924,4007,1699,14,456,2574,202,1438,981,1701,419,418,2426,826,652,558,1081,1696,1773,1149,762,4006,1956,405,1439,922,824,4004,417,4005,1423,3996,198,183,897,2650,288,381,378,1738,375,574,384,576,377,3999,3076,3203,260,1148,3997,4001,199,1678,1737,755,578,575,379,4000,3998,904,1736],"class_list":["post-1816","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-ajmalin","tag-amantadin","tag-amiodaron","tag-amisulprid","tag-amitriptylin","tag-anti-parkinson-mittel","tag-antiarrhythmika","tag-antidepressiva","tag-antihistaminika","tag-antikonvulsiva","tag-azithromycin","tag-budipin","tag-chemotherapeutika","tag-chemotherapie","tag-chinidin","tag-chinin","tag-chloralhydrat","tag-chloroquin","tag-chlorpromazin","tag-clarithromycin","tag-clemastin","tag-clindamycin","tag-clomipramin","tag-clozapin","tag-co-trimoxazol","tag-cotrimoxazol","tag-desipramin","tag-diphenhydramin","tag-disopyramid","tag-diuretika","tag-doxepin","tag-erythromycin","tag-fluorchinolone","tag-fluorochinolone","tag-fluoxetin","tag-fluphenazin","tag-foscarnet","tag-gatifloxacin","tag-halofantrin","tag-haloperidol","tag-herzrhythmusstoerungen","tag-hydroxyzin","tag-imipramin","tag-immunsuppressiva","tag-indapamid","tag-ioxaglinsaeure","tag-levofloxacin","tag-levomethadon","tag-lipidsenker","tag-lithium","tag-long-qt-syndrom","tag-m-parkinson","tag-m2-ionenkanal-blocker","tag-makrolide","tag-malaria","tag-malaria-tropica","tag-maprotilin","tag-mefloquin","tag-melperon","tag-migraene","tag-moxifloxacin","tag-muskelrelaxanzien","tag-naratriptan","tag-neuroleptika","tag-nichtselektive-monoamino-wiederaufnahme-hemmer","tag-nootropika","tag-octreotid","tag-olanzapin","tag-parkinson-syndrom","tag-paroxetin","tag-pentamidin","tag-pimozid","tag-plasmodium-falciparum","tag-probucol","tag-propafenon","tag-qt-zeit","tag-qt-zeit-verlaengerung","tag-rhythmusstoerungen","tag-risperidon","tag-roentgenkontrastmittel","tag-roxithromycin","tag-selektive-serotonin-wiederaufnahme-hemmer","tag-serotonin-wiederaufnahme-hemmer","tag-sertindol","tag-sertralin","tag-sotalol","tag-sparfloxacin","tag-spiramycin","tag-ssri","tag-sulpirid","tag-sumatriptan","tag-tacrolimus","tag-tamoxifen","tag-thioridazin","tag-tiaprid","tag-tizanidin","tag-torsade-de-pointes","tag-trimethoprim-sulfamethoxazol","tag-triptane","tag-trizyklische-antidepressiva","tag-valproat","tag-valproinsaeure","tag-venlafaxin","tag-vincamin","tag-virustatika","tag-ziprasidon","tag-zolmitriptan"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1816"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1816\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}